Myriad Genetics Inc
(MYGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 53,207 | 47,358 | 35,937 | 96,201 | 92,420 |
| Marketable Securities | 37,173 | 49,171 | 91,283 | 31,851 | 24,740 |
| Receivables | 5,943 | 5,435 | 5,761 | 3,783 | 3,330 |
| Other current assets | 0 | 0 | 0 | 0 | 2,350 |
| TOTAL | $99,857 | $105,627 | $137,199 | $133,471 | $122,840 |
| Non-Current Assets | |||||
| PPE Net | 12,567 | 12,440 | 12,731 | 12,515 | 23,560 |
| Investments And Advances | 43,585 | 39,725 | 18,736 | 12,779 | 23,060 |
| Other Non-Current Assets | 2,915 | 3,452 | 3,480 | 3,480 | 3,480 |
| TOTAL | $59,067 | $55,617 | $34,947 | $28,774 | $50,100 |
| Total Assets | $158,924 | $161,244 | $172,145 | $162,245 | $161,480 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,743 | 5,703 | 9,657 | 5,422 | 4,590 |
| Accrued Expenses | 3,863 | 3,400 | 3,083 | 2,937 | 4,340 |
| Other current liabilities | N/A | N/A | N/A | N/A | 12,760 |
| TOTAL | $20,357 | $21,972 | $32,584 | $23,014 | $21,700 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 9,751 | 12,869 | 19,843 | 14,655 | N/A |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $20,357 | $21,972 | $32,584 | $23,014 | $21,700 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,506 | 47,089 | N/A | 46,531 | N/A |
| Common Shares | 238 | 235 | 234 | 233 | 230 |
| Retained earnings | -63,481 | -61,022 | -59,837 | -57,650 | -55,920 |
| Other shareholders' equity | 346 | 818 | 364 | 263 | 60 |
| TOTAL | $138,567 | $139,272 | $139,562 | $139,231 | $139,770 |
| Total Liabilities And Equity | $158,924 | $161,244 | $172,145 | $162,245 | $161,470 |